SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Meghmani Finechem - Quaterly Results

21 Jul 2022 Evaluate
The topline stands at Rs. 5328.50 millions for the June 2022 quarter. The mentioned figure indicates a rise of about 83.52% as against Rs. 2903.45 millions during the year-ago period.The Total revenue for the quarter ended June 2022 of  Rs. 1077.92  millions  grew by 191.68% from Rs. 369.56 millions.Operating profit for the quarter ended June 2022 rose to 1894.93 millions as compared to 926.56 millions of corresponding quarter ended June 2021.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202206 202106 % Var 202206 202106 % Var 202203 202103 % Var
Sales 5328.50 2903.45 83.52 5328.50 2903.45 83.52 15509.41 8286.00 87.18
Other Income 20.30 1.73 1073.41 20.30 1.73 1073.41 41.11 21.89 87.80
PBIDT 1894.93 926.56 104.51 1894.93 926.56 104.51 5135.97 2635.17 94.90
Interest 111.22 123.76 -10.13 111.22 123.76 -10.13 442.70 291.14 52.06
PBDT 1783.71 802.80 122.19 1783.71 802.80 122.19 4693.27 2344.03 100.22
Depreciation 220.39 212.97 3.48 220.39 212.97 3.48 859.06 735.45 16.81
PBT 1563.32 589.83 165.05 1563.32 589.83 165.05 3834.21 1608.58 138.36
TAX 485.40 220.27 120.37 485.40 220.27 120.37 1306.36 600.19 117.66
Deferred Tax 204.93 117.33 74.66 204.93 117.33 74.66 609.63 318.51 91.40
PAT 1077.92 369.56 191.68 1077.92 369.56 191.68 2527.85 1008.39 150.68
Equity 415.50 415.53 -0.01 415.50 415.53 -0.01 415.50 415.53 -0.01
PBIDTM(%) 35.56 31.91 11.44 35.56 31.91 11.44 33.12 31.80 4.13

Epigral Share Price

1063.65 -48.70 (-4.38%)
11-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
SRF 2658.95
BASF India 3253.95
Tata Chemicals 741.00
Pidilite Inds. 1498.80
Deepak Nitrite 1611.15
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: